EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Risk Factors for Acute Rejection in Pediatric Lung Transplantation and Its Impact on Graft Failure

Sophie Li iD, Spoorthi Kamepalli, David Moreno McNeill, Selena Li, Abbas Rana

Pediatric Pulmonology · 2026-03 · 61 (3)

DOI: 10.1002/ppul.71547 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Pulmonology, online erschienen am 03.03.2026. Verfasst von Sophie Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Student Affairs, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Lung Transplantation, Graft Rejection. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Although acute rejection is a common complication of lung transplantation, few studies have analyzed risk factors for acute rejection in pediatric lung transplant patients. The purpose of this study was to examine risk and protective factors for acute rejection in pediatric lung transplantation and its impact on graft failure.

Methods

A retrospective analysis was performed on lung transplant data for a cohort of 906 pediatric patients from the Organ Procurement and Transplantation Network (OPTN) Database between October 1, 1987, and June 30, 2023. Multivariable logistic regression was conducted to identify risk and protective factors for acute rejection, adjusting for induction and maintenance therapy agents. Multivariable Cox proportional hazards regression analysis was performed to evaluate the impact of acute rejection on graft failure.

Results

Multivariable logistic regression analysis identified cyclosporine maintenance therapy (adjusted OR, 4.26; 95% CI, 2.89–6.27), ischemia time ≥ 9 h (adjusted OR, 4.73; 95% CI, 1.25–17.85), and two mismatches at the HLA‐A locus (adjusted OR, 1.42; 95% CI, 1.02–1.96) as significant risk factors for acute rejection. Recipient Hispanic ethnicity (adjusted OR, 0.56; 95% CI, 0.35–0.91) and antithymocyte globulin induction therapy (adjusted OR, 0.55; 95% CI, 0.36–0.85) were significant protective factors. Acute rejection was independently associated with graft failure.

Conclusion

We identified risk and protective factors for acute rejection in pediatric lung transplant recipients. Findings from this study will contribute to the current understanding of recipient and donor characteristics that may impact rejection risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung TransplantationGraft RejectionHumansRisk FactorsFemaleRetrospective StudiesChildMaleChild, PreschoolInfantAdolescentImmunosuppressive AgentsAcute DiseaseCyclosporineProportional Hazards Models

Stichwörter der Autor:innen

lung transplantationpediatricsrisk factors

Substanzen

Immunosuppressive AgentsCyclosporine

Autor:innen und Institutionen

  • Department of Student Affairs, Baylor College of Medicine, Houston, Texas, USA.
  • Division of Pediatric Pulmonology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
  • Division of Abdominal Transplant, Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas, USA.

ORCID-Profile: Sophie Li

Zitieren

APA

Li, S., Kamepalli, S., McNeill, D. M., Li, S., & Rana, A. (2026). Risk Factors for Acute Rejection in Pediatric Lung Transplantation and Its Impact on Graft Failure. Pediatric Pulmonology, 61(3). https://doi.org/10.1002/ppul.71547

Vancouver

Li S, Kamepalli S, McNeill DM, Li S, Rana A. Risk Factors for Acute Rejection in Pediatric Lung Transplantation and Its Impact on Graft Failure. Pediatric Pulmonology. 2026;61(3). doi:10.1002/ppul.71547

BibTeX
@article{Li2026,
  author = {Li, Sophie and Kamepalli, Spoorthi and McNeill, David Moreno and Li, Selena and Rana, Abbas},
  title = {Risk Factors for Acute Rejection in Pediatric Lung Transplantation and Its Impact on Graft Failure},
  journal = {Pediatric Pulmonology},
  year = {2026},
  volume = {61},
  number = {3},
  doi = {10.1002/ppul.71547}
}
Kostenlos starten →